Servier Canada

Servier Canada Oncology

Committed to research in rare cancers

Explore the oncology hub to learn more about our therapeutic areas and portfolio of products.

Explore our products

Our products

Voranigo vorasidenib tablets logoEXPLORE VORANIGO®
TIBSOVO logo; TIBSOVO (ivosidenib tablets).EXPLORE TIBSOVO®
ASPARLAS logo; ASPARLAS calaspargase pegol for injectionEXPLORE ASPARLAS®
ONCASPAR logo; ONCASPAR pegaspargase injection.EXPLORE ONCASPAR®
FOLOTYN logo; FOLOTYN® (pralatrexate injection)EXPLORE FOLOTYN®

Our therapeutic areas

Gliomahttps://servier-oncohub.nyc3.digitaloceanspaces.com/app/uploads/2025/01/29172946/Icons.pngCholangiocarcinoma (CCA)https://servier-oncohub.nyc3.digitaloceanspaces.com/app/uploads/2025/04/14101033/Icons-CCA.svgAcute Myeloid Leukemia (AML)https://servier-oncohub.nyc3.digitaloceanspaces.com/app/uploads/2025/04/14101032/Icons-AML.svgAcute Lymphoblastic Leukemia (ALL)https://servier-oncohub.nyc3.digitaloceanspaces.com/app/uploads/2025/04/14101031/Icons-ALL.svgPeripheral T-cell lymphoma (PTCL)https://servier-oncohub.nyc3.digitaloceanspaces.com/app/uploads/2025/04/14101035/Icons-PTCL.svg

Our patient support program

Support for your patients throughout their treatment

Learn more

References:

  1. ASPARLAS® Product Monograph. Servier Canada. March 8, 2024.
  2. FOLOTYN® Product Monograph. Servier Canada. October 19, 2018.
  3. ONCASPAR® Product Monograph. Servier Canada. August 20, 2024.
  4. TIBSOVO® Product Monograph. Servier Canada. July 19, 2024.
  5. VORANIGO® Product Monograph. Servier Canada. August 27, 2024.
Back to top

Stay Connected with Servier Canada

Stay up to date on disease information, treatment options, our products, and patient support programs.

Sign Up